Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Treatment-Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Not applicableActive Not RecruitingNCT07352748
What this trial is testing

Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa

Who this might be right for
Metastatic Prostate Cancer
Universita di Verona 30
Not applicableEnded earlyNCT01290237
What this trial is testing

Use of a Loading Dose of Vancomycin in Pediatric Dosing

Who this might be right for
Infection
Boston Children's Hospital 59
Large-scale testing (Phase 3)Looking for participantsNCT05316935
What this trial is testing

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Who this might be right for
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance
Xiaojun Chen 80
Not applicableNot Yet RecruitingNCT06113627
What this trial is testing

Lymphatic Response to Resistance Exercise in Breast Cancer Survivors

Who this might be right for
Breast Cancer LymphedemaSurvivorshipLymphedema of Upper Limb
University of Malaga 170
Not applicableStudy completedNCT03409393
What this trial is testing

Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderFirst Episode Psychosis+2 more
Rigshospitalet, Denmark 27
Large-scale testing (Phase 3)Active Not RecruitingNCT04964934
What this trial is testing

Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 315
Testing effectiveness (Phase 2)Study completedNCT02346578
What this trial is testing

Comparative Study of Alternative Antiandrogen (AA) Therapy and Early Initiating of Enzalutamide for Castration-resistant Prostate Cancer (CRPC) After Combined Androgen Blockade (CAB) Therapy.

Who this might be right for
Castration-resistant Prostate Cancer
Taro Iguchi, MD, PHD 104